ZOLL LifeVest Prescribed by Physicians at
Every U.S. News and World Report “Honor Roll” Hospital


Editors at magazine analyze data from over 5000 medical centers to provide its readers a list of the best hospitals in the United States. Only 170 hospitals were ranked in one or more specialties and of those, just 19 were selected for its prestigious “Honor Roll” designation. ZOLL is proud to announce that the ZOLL LifeVest® Wearable Defibrillator has been prescribed for patients by physicians at all of the “Honor Roll” hospitals.

The LifeVest is a unique, non-invasive defibrillator worn by patients at increased risk for sudden cardiac arrest (SCA). The LifeVest constantly monitors the patient’s heart and, if a life-threatening heart rhythm is detected, delivers a potentially life-saving treatment shock, without bystander intervention. The entire event, from detecting a life-threatening arrhythmia to automatically delivering a treatment shock, usually occurs in less than a minute. Timely defibrillation is the single most important factor in saving a SCA victim’s life; the LifeVest has a 98 percent first treatment shock success rate for treating patients with SCA.

The LifeVest is considered a treatment option for patients who meet certain criteria, including but not limited to:
Immediately after a heart attack during the recovery and evaluation process to determine if the patient should receive an ICD;
Before and after coronary bypass and angioplasty procedures to allow for recovery and evaluation for the need of an ICD;
Patients awaiting a heart transplant or patients with terminal diseases;
Recently diagnosed or suspected conditions such as cardiomyopathy, which might require additional follow-up and evaluation; or
After an ICD is removed due to complications or other medical reasons.

The LifeVest also may be prescribed by a physician for patients who are awaiting surgery for an ICD, until their heart gets stronger, or their physician decides on another course of treatment.

The LifeVest has been prescribed for over 16,000 patients and is covered by Medicare and most other insurers for those patients at high risk of cardiac arrest.

The 19 “Honor Roll” hospitals, listed in order here, include such esteemed medical facilities as Johns Hopkins in Baltimore which is ranked number one; the Mayo Clinic in Rochester, Minn.; Ronald Reagan UCLA Medical Center in Los Angeles; Cleveland Clinic in Ohio; Massachusetts General Hospital in Boston; New York Presbyterian University Hospitals of Columbia and Cornell in New York; University of California, San Francisco Medical Center; Brigham and Women’s Hospital in Boston; Duke University Medical Center, Durham, N.C.; Hospital of the University of Pennsylvania, Philadelphia; University of Washington Medical Center in Seattle; Barnes-Jewish Hospital/Washington University, St. Louis; University of Michigan Hospitals and Health Centers, Ann Arbor; University of Pittsburgh Medical Center; Vanderbilt University Medical Center, Nashville; Stanford Hospitals and Clinics, Stanford, Calif.; University of Chicago Medical Center; Cedars-Sinai Medical Center, Los Angeles; and Yale-New Haven Hospital, New Haven, Conn.

To learn more about the LifeVest, please visit: www.zoll.lifecor.com.